Home NDC 53346-1363 DR. RECKEWEG R63 Endangitin
Product NDC 53346-1363
11-digit product format 533461363
Labeler code 53346
Product ID 53346-1363_d858c247-2068-4e99-be9a-7a2cb1ed9e8f
Type HUMAN OTC DRUG
Nonproprietary name Aesculus hippocastanum 2X, Potentilla anserina 2X, Cuprum aceticum 6X, Secale cornutum 4X, Tabacum 4X, Veratrum album 6X
Dosage form LIQUID
Route ORAL
Labeler PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 1986-06-01
Marketing end 0000-00-00
Substance HORSE CHESTNUT; POTENTILLA ANSERINA FLOWERING TOP; CUPRIC ACETATE; CLAVICEPS PURPUREA SCLEROTIUM; TOBACCO LEAF; VERATRUM ALBUM ROOT
Active strength 2 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 53346-1363-5 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 53346-1363-5 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 53346-1363-5 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 53346-1363-5 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 53346-1363-5 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 53346-1363-5 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 53346-1363-5 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53346-1363-5 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53346-1363-5 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 53346-1363-5 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 53346-1363-5 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 53346-1363-5 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 53346-1363-5 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 53346-1363-5 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 53346-1363-5 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 53346-1363-5 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 53346-1363-5 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 53346-1363-5 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 53346-1363-5 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 53346-1363-5 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 53346-1363-5 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 53346-1363-5 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 53346-1363-5 DR. RECKEWEG R63 EndangitinCombination product 50 mL in 1 BOTTLE LIQUID 50 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CLAVICEPS PURPUREA SCLEROTIUM ACTIVE INGREDIENT 01G9XEA93N DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 CUPRIC ACETATE ACTIVE INGREDIENT 39M11XPH03 DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 HORSE CHESTNUT ACTIVE INGREDIENT 3C18L6RJAZ DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 POTENTILLA ANSERINA FLOWERING TOP ACTIVE INGREDIENT H00Y243SK0 DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 TOBACCO LEAF ACTIVE INGREDIENT 6YR2608RSU DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 VERATRUM ALBUM ROOT ACTIVE INGREDIENT QNS6W5US1Z DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 CLAVICEPS PURPUREA SCLEROTIUM ACTIVE MOIETY 01G9XEA93N DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 CUPRIC CATION ACTIVE MOIETY 8CBV67279L DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 HORSE CHESTNUT ACTIVE MOIETY 3C18L6RJAZ DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 POTENTILLA ANSERINA FLOWERING TOP ACTIVE MOIETY H00Y243SK0 DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 TOBACCO LEAF ACTIVE MOIETY 6YR2608RSU DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 VERATRUM ALBUM ROOT ACTIVE MOIETY QNS6W5US1Z DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 ALCOHOL INACTIVE INGREDIENT 3K9958V90M DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 WATER INACTIVE INGREDIENT 059QF0KO0R DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 53346-1363 DR. RECKEWEG R63 ENDANGITIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, POTENTILLA ANSERINA 2X, CUPRUM ACETICUM 6X, SECALE CORNUTUM 4X, TABACUM 4X, VERATRUM ALBUM 6X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO] 1 Legacy NDC, 1 package rows 20130514_aa7de1fd-3dd7-4d99-8652-5186f0484a58.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 53346-1363-5 53346136305 50 mL in 1 BOTTLE 50 ml Historical